CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 9 No. 10
 

Improving Minority Access to Genetic Counseling for Cancer Risk

By Jennie Hounshell, Kirstin Knox, Cecilia Tomori, and Charles L. Bennett, MD, PhD

| October 1, 2000

The Second Annual Robert H. Lurie Comprehensive Cancer Center Health Policy Symposium, held last year in Chicago, was entitled “Cancer, Reaching Medically Underserved Populations: Low Literacy and Culturally Specific Barriers.”

This is the fourth in a series of reports on the conference presentations, prepared for ONI by researchers at Northwestern Medical School, that will put the discussions into a broader context. This month’s article reviews a presentation by Chanita Hughes, PhD, Georgetown University Medical Center, Lombardi Cancer Center, Washington, DC.


Introduction

CHICAGO—Disparities in cancer incidence and mortality between whites and ethnic minorities in the United States persist,[1] suggesting a need for targeted efforts to increase cancer screening and prevention measures among ethnic minorities and the medically underserved.

Such efforts include increasing minority participation in cancer prevention trials (see ONI September 2000, page 3) and implementing new technologies for cancer screening and early detection, some of which have only recently become available to the public.

One such technology is genetic screening for mutations in cancer susceptibility genes. Such screening accompanied by genetic counseling enables individuals to assess their risk of developing cancer and decide which type of cancer screening and cancer prevention measures to take.

Unfortunately, genetic screening may not be accessible to all, especially to ethnic minorities and the medically under-served, who may lack essential knowledge about cancer screening or who may be unfamiliar with genetic testing.

In addition, minority communities may have significant concerns about being used as guinea pigs for new medical tests and procedures. These concerns may lead to underutilization of genetic screening for cancer risk.

This paper will address the work of Chanita Hughes, PhD, of Georgetown University Medical Center, on ethnic differences in knowledge and attitudes about genetic testing for breast cancer risk, as presented at the Robert H. Lurie Comprehensive Cancer Center’s Symposium on Cancer: Reaching Medically Under-served Populations.

Goals of Genetic Counseling

Approximately 5% of women diagnosed with breast cancer each year carry a mutation in the BRCA1 gene.[2] Women with a BRCA1 mutation have a nearly eightfold higher (80% to 85%) lifetime risk of developing breast cancer and up to 30-fold higher lifetime risk of developing ovarian cancer (approximately 44%), compared with women in the general population (about 11% and 1.5% to 2%, respectively).[3]

Genetic testing to detect mutations in BRCA1 and assess cancer risk is becoming available to an increasing number of women. To provide information and alleviate patient distress about genetic testing, pre- and post-test counseling and patient education are crucial.

According to Dr. Chanita Hughes, the goals of pretest education and counseling include providing education about genes, inheritance, susceptibility, and risk assessment. In addition, counseling sessions should address the benefits and risks of testing, including confidentiality issues, effects on family members, and the potential for insurance discrimination.[4]

In pretest counseling sessions, Dr. Hughes’ goal is not to encourage or discourage testing but rather to provide information so that women can make an informed decision about whether to pursue genetic testing.

Goals of post-test counseling include discussing disclosure, risks of developing cancer, and recommendations for screening and surveillance. Supportive counseling is also available.

Cultural Influences on Testing

In a series of studies on cultural influences on genetic testing, Dr. Caryn Lerman, Dr. Hughes, and their colleagues show that black and white women have different views and levels of knowledge about genetic testing, and respond differently to education and counseling interventions prior to undergoing genetic testing for BRCA1 mutations.[4,5]

In one study, Hughes et al found that white women reported more exposure to written and verbal materials about genetic testing than did black women. A greater percentage of white women had used genetic testing, and they had significantly greater knowledge levels about breast cancer genetics and genetic testing.

In a second study, participants were randomized to receive either a genetic testing education intervention alone or an education intervention accompanied by counseling about genetic testing.

Education efforts focused on identifying individual risk factors and patterns of inheritance, and addressed the benefits, limitations, and risks of genetic testing.

Counseling topics included women’s experiences with cancer in their families, the anticipated impact of positive/negative results or of declining testing, and coping resources and skills.

Black Women’s Concerns

In this study, black and white women in both intervention arms were found to have similar attitudes about the benefits of genetic testing, although black women tended to rate the benefits of testing significantly higher than did white women. However, black and white women in both intervention arms had very different views on the negative aspects of genetic testing. Black women were considerably more concerned about the effects of testing on their family members and reported more emotional strain.[4,5]

When the counseling and education intervention arm was compared with the education intervention arm, the researchers found that counseling increased the number of concerns and decreased the number of benefits that participants identified.

For black women, education and counseling led to a greater increase in intention to undergo genetic testing, compared with education alone, while for white women there was no difference in the impact of the two intervention arms.

Because differences between the black and white women persisted after controlling for sociodemographic factors, the observed differences may be ascribed to cultural beliefs and values.

For example, women from diverse ethnic and cultural backgrounds may have different attitudes toward temporal orientation (eg, emphasizing the present rather than the future); cancer fatalism; religion and spirituality; and family relationships.

Conclusion

Reported differences between black and white women in knowledge levels and attitudes about genetic testing raise the concern that education and counseling efforts for women at increased risk for cancer are not reaching black women.[4]

In addition, counseling and education efforts about the benefits, limitations, and risks of genetic testing may not address the specific concerns of black women regarding genetic testing, such as their distrust of the medical community and concerns about the effects of testing on family members.[4,5]

Targeted genetic counseling programs addressing the specific cultural beliefs and concerns of participants may successfully increase knowledge about and awareness of genetic testing.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





1. American Cancer Society: Cancer Facts and Figures 2000. Atlanta, American Cancer Society, 2000.

2. Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994.

3. Ford D, Easton DF, Bishop DT, et al: Risks of cancer in BRCA1-mutation carriers: Breast Cancer Linkage Consortium. Lancet 343:692-695, 1994.

4. Hughes C, Gomez-Caminero A, Benkendorf J, et al: Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns 32:51-62, 1997.

5. Lerman C, Hughes C, Benkendorf J, et al: Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev 8:361-367, 1999.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy